News Jun 18, 2020

Clara Biotech Selected to Join 2020 MassChallenge Boston

MassChallenge Boston Announces 2020 Cohort 100 early-stage, high-impact companies gain access to global network of experts and resources. Two dates set for the public to connect with new cohort online. JUNE 2, 2020 (BOSTON, MA) – MassChallenge, a global network of zero-equity startup accelerators, today announced the 100  early-stage startups that will join the 2020 MassChallenge […]

News Jun 18, 2020

Lab in KU Medical Center incubator switches to coronavirus test to meet community need

June 11, 2020 By Anne Christiansen-Bullers Jasmine Salem, lab technician at Sinochips Diagnostics, prepares pipette tips for for a machine called the Roche Cobas E411. It’s part of the testing process that ultimately delivers results about the coronavirus that leads to COVID-19. Sinochips Diagnostics, a private laboratory operating on the campus of the University of […]

Press Releases Jun 02, 2020

LIGAND CEO ISSUES LETTER TO CAPTISOL CUSTOMERS

June 01, 2020 SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that Chief Executive Officer John Higgins issued a letter to Ligand’s Captisol® customers. The full text of that letter is as follows: To Our Valued Captisol Customers, Ligand is in a period of momentous planning and scale-up. As you may know, Captisol is a key ingredient […]

News Jun 02, 2020

REMDESIVIR, THE DRUG THERAPY RECENTLY AUTHORIZED UNDER EMERGENCY-USE PROTOCOL FOR COVID-19, CONTAINS CRUCIAL INGREDIENT FROM THE UNIVERSITY OF KANSAS

Mon, 06/01/2020 LAWRENCE — When the Food and Drug Administration issued an emergency-use authorization for the investigational pharmaceutical remdesivir to treat COVID-19 on May 1, in part it was due to pioneering work performed by pharmaceutical chemists at the University of Kansas School of Pharmacy in 1990. Today, KU graduates still hold important jobs at […]

Press Releases May 27, 2020

FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCKTM (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

May 15, 2020 QINLOCK Significantly Improved Progression-Free Survival and Showed Clinically Meaningful Overall Survival in INVICTUS Phase 3 Study NDA Approved 3 Months Prior to Action Date Under FDA’s Real Time Oncology Review (RTOR) Deciphera to Host Conference Call Today at 5:00 PM Eastern Time   WALTHAM, Mass.–(BUSINESS WIRE)–May 15, 2020– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) […]

News May 26, 2020

KU Professor, Doctorate Student receive NSF grant for hydrogen fuel cell research

By Sarah Motter | Posted: Thu 1:40 PM, May 21, 2020 LAWRENCE, Kan. (WIBW) — Avium LLC will receive a two-year, $750,000 Small Business Innovation Research grant from the National Science Foundation. Avium will use the grant to popularize and make it easier to own cars with hydrogen fuel cells, while also making hydrogen production friendlier to the environment. […]

Press Releases May 05, 2020

ADARE PHARMACEUTICALS, INC. ACQUIRES ORBIS BIOSCIENCES

Lawrenceville, NJ, and Lenexa, KS – May 4, 2020 Kansas-based pharmaceutical technology company develops customized formulations and intellectual property Deal includes platforms that can be dosed in oral, injectable and otic (ear) formulations Acquisition expands Adare’s technology platforms and product development capabilities Adare Pharmaceuticals, Inc., a clinical-stage pharmaceutical company and leading global provider of advanced […]

News Apr 07, 2020

Universities Turn on the Faucet of Entrepreneurship so Corporations Can Tap In

This story is part of a series that explores how Kansas City corporations are supporting entrepreneurship and why corporate engagement is important. For more, explore the new We Create Corporate Engagement report. By Kelly Scanlon March 17, 2020 About a half dozen people pore over computer monitors arranged in two workstation clusters. Others are busy at […]

News Mar 31, 2020

Biotech firm seeks to advance novel exosome isolation-based therapy for COVID-19 into clinical trials

By: Startland Staff–   March 27, 2020 COVID-19, Fusion Medical Animation Editor’s note: The following is part of Startland News’ ongoing coverage of the impact of Coronavirus (COVID-19) on Kansas City’s entrepreneur community, as well as how innovation is helping to drive a new normal in the ecosystem. Click here to follow related stories as they develop. As the global […]

News Mar 31, 2020

Lawrence-based Clara Biotech seeking clinical trial for possible COVID-19 therapy

photo by: Sara Shepherd/Journal-World File Photo By: Conner Mitchell A Lawrence biotechnology company is in the process of solidifying clinical trials for a therapy that could drastically reduce the more complicated symptoms of COVID-19. Clara Biotech, based on the University of Kansas’ west campus, says it has developed a way to directly target infected lung tissue […]